Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
SGYPW was delisted on the 6th of December, 2016.
0 hedge funds and large institutions have $0 invested in Synergy Pharmaceuticals, Inc. - Warrants in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.
108% more call options, than puts
Call options by funds: $6.18M | Put options by funds: $2.97M
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $289K → $0 (-$289K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$124K |
| 2 |
Twin Tree Management
Dallas,
Texas
|
-$21K |
SGYPW Hedge Fund Activity: Q4 2016 in Review
0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q4 2016, worth a combined $0 — down 100% from $289K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SGYPW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $124K sold.
- 0 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q4 2016, down from 3 in Q3 2016.
- Funds reported $0 of Synergy Pharmaceuticals, Inc. - Warrants stock for Q4 2016, down 100% quarter-over-quarter.
- 0 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q4 2016 and 3 closed out, a net change of -3 holders.
- The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q4 2016 was Sabby Management, an estimated $124K sold.
Based on aggregated 13F filings for Q4 2016.